Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $34,700 | 15 | 40.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $24,000 | 11 | 28.2% |
| Food and Beverage | $12,729 | 443 | 15.0% |
| Consulting Fee | $10,810 | 7 | 12.7% |
| Travel and Lodging | $2,749 | 9 | 3.2% |
| Education | $137.63 | 4 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardiovascular Systems Inc. | $61,620 | 60 | $0 (2023) |
| Abbott Laboratories | $6,171 | 15 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $4,171 | 11 | $0 (2023) |
| Boston Scientific Corporation | $3,492 | 147 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,879 | 34 | $0 (2020) |
| Endologix LLC | $1,622 | 58 | $0 (2024) |
| ABIOMED | $1,296 | 30 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $617.16 | 38 | $0 (2024) |
| Inari Medical, Inc. | $332.76 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $287.05 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,097 | 57 | Boston Scientific Corporation ($562.53) |
| 2023 | $7,400 | 46 | Abbott Laboratories ($5,967) |
| 2022 | $10,430 | 32 | Cardiovascular Systems Inc. ($9,520) |
| 2021 | $3,238 | 29 | Cardiovascular Systems Inc. ($1,864) |
| 2020 | $6,773 | 32 | Cardiovascular Systems Inc. ($6,070) |
| 2019 | $15,893 | 91 | Cardiovascular Systems Inc. ($14,086) |
| 2018 | $24,216 | 96 | Cardiovascular Systems Inc. ($17,975) |
| 2017 | $15,080 | 106 | Cardiovascular Systems Inc. ($11,431) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Food and Beverage | In-kind items and services | $40.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $167.22 | General |
| Category: VTE | ||||||
| 11/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: General - Atherectomy_PI | ||||||
| 10/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: Coronary | ||||||
| 10/11/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Coronary | ||||||
| 10/07/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.58 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/28/2024 | Endologix LLC | AFX2 Bifurcated Endograft System (Device) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Surmodics, Inc. | Pounce Thrombectomy (Device), Pounce Venous Thrombectomy System, Pounce Thrombectomy System | Food and Beverage | Cash or cash equivalent | $29.70 | General |
| Category: Pounce Arterial Packaged Assembly, Sterile | ||||||
| 09/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $134.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Endologix LLC | AFX2 Bifurcated Endograft System (Device) | Food and Beverage | In-kind items and services | $38.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: General - Stents_IC | ||||||
| 07/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: General - Stents_IC | ||||||
| 06/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 06/25/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.09 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| Category: Coronary | ||||||
| 06/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | Endologix LLC | Alto Abdominal Stent Graft System (Device) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $42.15 | General |
| Category: Not Applicable | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 05/29/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Coronary | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ECLIPSE | Cardiovascular Systems Inc. | $28,800 | 14 |
| Evaluation of Treatment Strategies for Severe Calcific Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting Stents: The ECLIPSE Trial (ECLIPSE) | Abbott Laboratories | $5,900 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,287 | 1,694 | $312,068 | $118,384 |
| 2022 | 17 | 1,563 | 1,995 | $360,363 | $130,694 |
| 2021 | 26 | 2,084 | 2,592 | $603,677 | $216,005 |
| 2020 | 27 | 1,875 | 2,428 | $549,555 | $191,317 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 373 | 645 | $142,545 | $57,463 | 40.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 139 | 146 | $40,588 | $13,912 | 34.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 119 | 208 | $30,368 | $12,115 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 151 | $23,103 | $10,046 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $26,130 | $9,026 | 34.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 35 | $21,245 | $6,859 | 32.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $7,380 | $2,390 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 191 | 197 | $6,895 | $2,005 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $4,653 | $1,576 | 33.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 33 | 33 | $2,277 | $691.68 | 30.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 34 | 34 | $1,564 | $566.44 | 36.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 13 | 13 | $1,937 | $539.80 | 27.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 50 | 50 | $1,300 | $464.56 | 35.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 21 | $1,008 | $388.71 | 38.6% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 21 | $588.00 | $180.95 | 30.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 23 | $253.00 | $96.60 | 38.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 13 | $234.00 | $64.35 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 529 | $116,909 | $46,618 | 39.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 62 | 62 | $37,634 | $13,504 | 35.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 99 | 101 | $42,723 | $13,109 | 30.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 138 | 244 | $35,624 | $13,058 | 36.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 126 | 133 | $36,974 | $12,704 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 140 | $21,420 | $9,108 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $18,760 | $6,428 | 34.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 31 | 32 | $15,744 | $5,383 | 34.2% |
About Dr. Georges Nseir, MD
Dr. Georges Nseir, MD is a Cardiovascular Disease healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528069408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Georges Nseir, MD has received a total of $85,125 in payments from pharmaceutical and medical device companies, with $2,097 received in 2024. These payments were reported across 489 transactions from 44 companies. The most common payment nature is "" ($34,700).
As a Medicare-enrolled provider, Nseir has provided services to 6,809 Medicare beneficiaries, totaling 8,709 services with total Medicare billing of $656,400. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Chandler, AZ
- Active Since 08/02/2005
- Last Updated 03/20/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1528069408
Products in Payments
- Coronary Orbital Atherectomy System (Device) $43,762
- Diamondback Coronary (Device) $17,866
- Peripheral Orbital Atherectomy System (Device) $5,775
- Resolute (Device) $1,968
- Impella (Device) $1,296
- Ovation (Device) $824.05
- CoreValve Evolut (Device) $689.90
- LifeVest (Device) $617.16
- GENERAL - VASCULAR INTERVENTION (Device) $461.31
- WATCHMAN (Device) $381.28
- AFX2 Bifurcated Endograft System (Device) $372.25
- FLOWTRIEVER CATHETER, S (Device) $332.76
- Alto Abdominal Stent Graft System (Device) $317.75
- GENERAL - STENTS (Device) $273.58
- ENTRESTO (Drug) $258.10
- FFRct (Device) $236.22
- VERQUVO (Drug) $217.95
- GENERAL VASCULAR INTERVENTION (Device) $193.28
- Vascular Lithotripsy (Device) $169.49
- AVVIGO Guidance System (Device) $162.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chandler
Dr. Pratik Dalal
Cardiovascular Disease — Payments: $162,416
Dr. Ashish Pershad, Md, MD
Cardiovascular Disease — Payments: $159,542
Dr. Marc Silver, M.d, M.D
Cardiovascular Disease — Payments: $93,495
Huy Phan, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $35,341
Dr. Daniel Einhorn, D.o, D.O
Cardiovascular Disease — Payments: $22,702
Dr. Gautam Kedia, M.d, M.D
Cardiovascular Disease — Payments: $21,365